<DOC>
	<DOC>NCT01535443</DOC>
	<brief_summary>Study to evaluate the safety and tolerability of PRO-155 Ophthalmic Solution 0.09 % in healthy volunteers.</brief_summary>
	<brief_title>Safety and Tolerability of PRO-155 Ophthalmic Solution 0.09% in Healthy Volunteers.</brief_title>
	<detailed_description>A phase I, open label and unicentric clinical trial to evaluate the safety and tolerability of PRO-155 Ophthalmic Solution 0.09 % in healthy volunteers.</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Cataract</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Healthy male and female. Age â‰¥ 18 years old at screening visit Any ocular or systemic condition. Patient with one blind eye. Visual acuity of 20/40 in any eye. Use of ocular or systemics medications. Contraindications or sensitivity to any component of the study treatments. Contact lens users. Ocular surgery within the past 3 months.. Women who were not using an effective means of contraception or who were pregnant or nursing. Participation in any studies of investigational drugs within 90 days previous to the inclusion.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>PRO-155</keyword>
	<keyword>Ocular NSAIDs</keyword>
	<keyword>Safety and tolerability</keyword>
	<keyword>Ocular Inflammation</keyword>
	<keyword>Ocular Paint</keyword>
</DOC>